TRIML2对质母细胞瘤中temozolomide耐药性的作用
Qiang Fu1, Peipei Chen2, Zening Wang1
1Department of Neurosurgery, First Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Annals of medicine and surgery (2012)
|March 20, 2025
概括
三方基因含有蛋白22 (TRIML2) 抑制了质母细胞瘤 (GBM) 中的泰莫索洛米德耐药性. 较低的TRIML2表达与耐药性相关,表明TRIML2是GBM治疗的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 获得的对temozolomide (TMZ) 的耐药性在质母细胞瘤 (GBM) 治疗中构成了重大挑战.
- TRIM家族成员TRIML2与癌症进展和治疗耐药性有关,但其在GBMTMZ耐药性中的作用尚不清楚.
研究的目的:
- 为了研究TRIML2在质母细胞瘤对temozolomide的耐药性中的作用.
- 确定TRIML2是否可以成为克服GBM中temozolomide耐药性的治疗标.
主要方法:
- 分析了来自耐托马胺和野生型U87细胞的RNA测序数据 (GEO: GSE193957).
- 通过细胞活动测试,伤口愈合测试和西部涂抹,验证TRIML2表达.
- 在耐药细胞中过度表达TRIML2后评估temozolomide耐药性,并分析患者瘤样本中的TRIML2表达.
主要成果:
- 与野生类型细胞相比,TRIML2表达在耐泰莫佐洛米德的U87细胞中明显较低.
- 抗性细胞中TRIML2的过度表达降低了它们对temozolomide的抗性,恢复了敏感性.
- 在耐泰莫佐洛米德的GBM瘤中,TRIML2的表达减少,而在对泰莫佐洛米德敏感的GBM瘤中则增加.
结论:
- 在质母细胞瘤中,TRIML2在temozolomide耐药性方面起着抑制作用.
- 在GBM患者中,TRIML2代表了一种潜在的新型治疗标,用于克服temozolomide耐药性.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.3K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K